Skip to Content

M A33 (Armodafinil 250 mg)

Pill with imprint M A33 is White, Capsule-shape and has been identified as Armodafinil 250 mg. It is supplied by Mylan Pharmaceuticals Inc..

Armodafinil is used in the treatment of narcolepsy; shift work sleep disorder; obstructive sleep apnea/hypopnea syndrome; chronic fatigue syndrome; adhd (and more), and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Armodafinil 250 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for M A33

Armodafinil

Imprint:
M A33
Strength:
250 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
CNS stimulants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
4 - Some potential for abuse
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-3433

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide